Holen Sie sich die Stockscreener-App
119.02
0.23%
0.27
Handel nachbörslich:
119.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$118.75
Offen:
$118.34
24-Stunden-Volumen:
1.37M
Relative Volume:
1.67
Marktkapitalisierung:
$8.51B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
11.08
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
-7.87%
1M Leistung:
-10.42%
6M Leistung:
-15.92%
1J Leistung:
-14.87%
1-Tages-Spanne:
$115.39
$119.54
1-Wochen-Bereich:
$115.39
$130.82
52-Wochen-Spanne:
$115.39
$179.60
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
119.02 | 8.38B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
459.68 | 109.23B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
206.49 | 18.33B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.84 | 15.66B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
217.01 | 13.92B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
113.85 | 11.77B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Will DaVita Inc. rebound enough to break evenJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
3 Warren Buffett Stocks to Buy Hand Over Fist in November - The Motley Fool
Zacks Research Downgrades DaVita (NYSE:DVA) to Strong Sell - MarketBeat
Creekmur Asset Management LLC Sells 2,584 Shares of DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Hits New 52-Week Low at USD 117.73 - Markets Mojo
Can DaVita Inc. (TRL) stock retain market dominanceJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Can DaVita Inc. stock beat market expectations this quarterEarnings Risk Summary & Community Consensus Picks - newser.com
Will DaVita Inc. stock outperform tech sector in 20252025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
Is DaVita Inc. stock bottoming outRecession Risk & Weekly High Return Forecasts - newser.com
Is DaVita Inc. stock trading at a premium valuationWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Research Alert: CFRA Keeps Hold View On Shares Of Davita Inc. - 富途牛牛
DaVita (NYSE:DVA) Sets New 52-Week Low After Earnings Miss - MarketBeat
Is a relief rally coming for DaVita Inc. holdersMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Custom strategy builders for tracking DaVita Inc.Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Is DaVita Inc. (TRL) stock safe for risk averse investorsTrade Signal Summary & Weekly High Conviction Trade Ideas - newser.com
How to integrate DaVita Inc. into portfolio analysis toolsTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
DaVita Inc. (DVA) Stock forecasts - Yahoo! Finance UK
DaVita (NYSE:DVA) Releases FY 2025 Earnings Guidance - MarketBeat
DaVita Inc. (DVA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y - sharewise.com
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges By GuruFocus - Investing.com Canada
Berkshire Hathaway Reduces Stake in DaVita (DVA) by $54.3 Millio - GuruFocus
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita (NYSE:DVA) Posts Earnings Results, Misses Expectations By $0.66 EPS - MarketBeat
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
Barclays Adjusts Price Target for DaVita (DVA), Maintains Equal-Weight Rating | DVA Stock News - GuruFocus
Barclays Adjusts Price Target on DaVita to $143 From $149 - MarketScreener
Deutsche Bank Adjusts Price Target on DaVita to $126 From $137 - MarketScreener
Davita Healthcare Partners stock hits 52-week low at $122.91 - Investing.com
Davita Healthcare Partners stock hits 52-week low at $122.91 By Investing.com - Investing.com Nigeria
DaVita price target lowered to $143 from $149 at Barclays - TipRanks
DaVita Inc. (NYSE:DVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Nisa Investment Advisors LLC Cuts Stock Position in DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. stock safe for conservative investors2025 Top Gainers & Trade Opportunity Analysis - newser.com
Sumitomo Mitsui Trust Group Inc. Grows Position in DaVita Inc. $DVA - MarketBeat
Asset Management One Co. Ltd. Reduces Stock Position in DaVita Inc. $DVA - MarketBeat
Total debt per share of DaVita Inc. – BER:TRL - TradingView
DVA Q3 2025 Deep Dive: Lower Volumes and Margin Compression Shape Outlook Amid Industry Uncertainty - The Globe and Mail
DaVita Inc. 3Rd Quarter 2025 Results - 富途牛牛
DaVita Inc. Reports Steady Q3 2025 Performance - TipRanks
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus
DaVita HealthCare: Q3 Earnings Snapshot - Stamford Advocate
DaVita (DVA) Q3 2025 Earnings Call Transcript - Fortune
DaVita’s Profit Misses Mark As Costs And Volume Drop Bite - Finimize
DaVita (DVA) Reaffirms Full-Year Guidance Despite Challenges - GuruFocus
DaVita Delivers Steady Growth But Misses On Earnings - Finimize
Davita shares fall on weak earnings, Berkshire cuts stake further By Investing.com - Investing.com Canada
DaVita Q3 2025 Earnings: Revenue Up 4.8%, EPS Misses EstimatesNews and Statistics - IndexBox
DaVita misses quarterly profit estimates on rising costs, lower volumes - TradingView
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita (NYSE:DVA) Reports Q3 In Line With Expectations - TradingView
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):